Corning to build pharma glass manufacturing plant in North Carolina

It’s expected the facility will create more than 300 new jobs in the area. (Corning)

Corning, the global glass manufacturer, said it will build a new pharmaceutical glass plant in North Carolina as part of its plan to spend $500 million to create thousands of new jobs in the U.S.

The facility, to be located in Durham County, will be a high-volume operation to produce Valor Glass, which is a damage-resistant glass that reduces particle contamination, breaks and cracks while significantly increasing throughput.

It’s expected the facility will create more than 300 new jobs in the area. It will be built next to a Corning Life Sciences manufacturing facility, allowing for interaction and cooperation between the two businesses, the company said.

Cambrex Webinar

Understanding the Importance of Crystallization Processes to Avoid Unnecessary Cost, Risk and Development Delays

Wednesday, May 27, 2020 | 10am ET / 7am PT

A well-developed crystallization process can produce suitable particles that can facilitate consistent filtration, drying and formulation of the API and allow confident and reliable manufacturing of the final drug product, while avoiding unnecessary cost, risk and development delays.

“Making this next-generation product requires a new, advanced manufacturing platform. We are proud to build this high-volume manufacturing facility for Valor Glass in Durham County,” Wendell P. Weeks, Corning’s chairman, CEO and president, said in a statement.

The facility is expected to be open by the end of 2019.

Read more on

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.